http://www.newsweek.com/ivermectin-covid-treatment-study-flawed-scientists-1627109

Scientists have cast doubts over an ivermectin study that said it had found a "favorable outcome" when giving the medicine to COVID patients.

The May 2021 study was a randomized, double-blinded trial in Israel that compared non-hospitalized patients receiving ivermectin for three days to those who were given a placebo. There were 47 patients in the ivermectin group, and 42 in the placebo group.